CD3(+)/CD45(+) and SMA-α(+) circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event.
Circulating microparticles (cMPs) are phospholipid-rich blebs of 0.1–1.0 μm in size shed from the plasma membrane of eukaryotic cells when injured, activated, or undergoing apoptosis. MPs have been shown to reflect cellular activation and/or tissue degeneration occurring in vivo.
| Autores: | , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión aceptada para publicación |
| Fecha de publicación: | 2016 |
| País: | España |
| Institución: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repositorio: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:10230/27086 |
| Acceso en línea: | http://hdl.handle.net/10230/27086 http://dx.doi.org/10.1016/j.ijcard.2016.01.211 |
| Access Level: | acceso abierto |
| Palabra clave: | Sistema cardiovascular -- Malalties Limfòcits |
| Sumario: | Circulating microparticles (cMPs) are phospholipid-rich blebs of 0.1–1.0 μm in size shed from the plasma membrane of eukaryotic cells when injured, activated, or undergoing apoptosis. MPs have been shown to reflect cellular activation and/or tissue degeneration occurring in vivo. |
|---|